SCHEMBL26258018

SCHEMBL26258018

C/C=C\CN(CC)CCCCCC

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 16/20 0.54
DNM1 Q05193 3/20 0.39
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22157408 1.00 KCNH2 (0.54) KCNH2DNM1PLA2G1BPLA2G2A
SCHEMBL22157506 0.98 KCNH2 (0.51) KCNH2DNM1PLA2G1BPLA2G2A
SCHEMBL27961138 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL15901718 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL27961113 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL15901281 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL22157415 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL15901895 0.91 KCNH2 (0.45) KCNH2DNM1
SCHEMBL6660072 0.91 KCNH2 (0.50) KCNH2PLA2G1BPLA2G2A
SCHEMBL27961069 0.91 KCNH2 (0.45) KCNH2DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234553-A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2023-08-30 EP disclosed